Finally, TRAF7’s involvement in multiple signaling pathways (e.g., MEKK3-ERK5, NF-κB, Robo4) poses a challenge for therapeutic targeting, as perturbation of TRAF7 could lead to unintended effects in other cellular contexts, such as immune modulation or tumor suppression. The gene discussed is MAP3K3; the disease is neoplasm.